ARTICLE | Clinical News

Fibrillex oral small molecule inhibitor of amyloid fiber formation regulatory update

October 22, 2001 7:00 AM UTC

Europe granted Orphan Drug designation for Fibrillex to treat secondary amyloidosis, a systemic form of amyloidosis associated with deposition of amyloid protein in the kidney, spleen, liver and adren...